Drugs Made In America Acquisition (DMII) Cash from Operations (2025)

Drugs Made In America Acquisition (DMII) reported Cash from Operations of 314864.0 for Q4 2025.

Drugs Made In America Acquisition (DMII) Cash from Operations (2025) Analysis & Trends

Drugs Made In America Acquisition (DMII) has 1 years of Cash from Operations data on file, last reported at 314864.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 EQV Ventures Acquisition 477.93 Mn 477.93 Mn - -121,028.00
2 GP-Act III Acquisition 312.80 Mn 312.80 Mn - 10,832.00
3 Berto Acquisition 311.56 Mn 311.56 Mn - -119,667.00
4 Churchill Capital Corp IX 310.79 Mn 310.79 Mn - -334,671.00
5 Centurion Acquisition 310.21 Mn 310.21 Mn - -72,157.00
6 WEN Acquisition 309.15 Mn 309.15 Mn - -195,797.00
7 Agriculture & Natural Solutions Acquisition 303.81 Mn 303.81 Mn - 1.32 Mn
8 Bold Eagle Acquisition 274.64 Mn 274.64 Mn - -171,240.00
9 Live Oak Acquisition Corp. V 265.88 Mn 265.88 Mn - -204,942.00
10 Drugs Made In America Acquisition 129.34 Mn 129.34 Mn - -314,864.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -314,864.00
Dec 31, 2025 -314,864.00